Methylation changes and INS-IGF2 expression predict progression in early-stage Wilms tumor

Deena Jalal, Mohamed Y. Ali, Naglaa Elkinaai, Abdelaziz S. Abdelaziz, Wael Zekri, Ahmed A. Sayed · 2024

Read Methylation changes and INS-IGF2 expression predict progression in early-stage Wilms tumor by Deena Jalal, Mohamed Y. Ali, Naglaa Elkinaai, Abdelaziz S. Abdelaziz, Wael Zekri, Ahmed A. Sayed (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11590261.txt.

Description

Deena Jalal and five co-authors look for early warning signs of relapse in Wilms tumor, the most common kidney cancer of childhood. Their study appeared in twenty twenty-four. Most children survive, but about fifteen percent relapse, and then survival falls hard.

The team compared tumor tissue from nine children who relapsed with nine who stayed in remission, all at early stages. Genome-wide scans of chemical tags on DNA showed clear patterns. Fourteen tag sites marked the groups apart, with looser tagging in gene-free regions among remission cases. A combined gene, INS-IGF2, ran higher in relapse tumors. The authors suggest these markers could guide closer watching and tailored treatment, while noting the sample was small.

Catalog record

CREATORDeena Jalal, Mohamed Y. Ali, Naglaa Elkinaai, Abdelaziz S. Abdelaziz, Wael Zekri, Ahmed A. Sayed
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11590261

Browse the full library · About the Tower of Babel